Zefei Jiang
Papers
2
Total Citations
169
H-Index
2
About
Zefei Jiang is a prominent researcher whose work bridges genetics and clinical medicine, with key contributions to the understanding of cystic fibrosis (CF) and cancer genetics. Jiang’s most cited study, “Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers” (2005, 114 citations), demonstrated that individuals carrying CFTR mutations—even without full-blown cystic fibrosis—face a significantly elevated risk of idiopathic chronic pancreatitis. This finding reshaped clinical screening and risk assessment for pancreatitis, highlighting the subtle but serious impacts of CF carrier status. In another influential paper (2003, 55 citations), Jiang revealed that ATM missense mutations are frequent in breast cancer patients, underscoring the role of DNA repair defects in cancer susceptibility. These contributions have not only advanced molecular diagnostics but also informed personalized risk management strategies. Jiang’s work is widely cited for its translational impact, bridging fundamental genetic insights with practical clinical applications. By uncovering hidden risks in seemingly healthy carriers and cancer patients, Jiang has left a lasting mark on both gastroenterology and oncology, making their research essential reading for students and clinicians alike.
Research Focus
Key Achievements
Top Papers
- 1Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers114 citations · 2005
- 2ATM missense mutations are frequent inpatients with breast cancer55 citations · 2003